This is a Sources Sought notice for a potential future contract to conduct preclinical screening of therapeutics for epilepsy, focusing on drug-resistant epilepsy, disease prevention, and pharmacokinetic studies. The work involves performing numerous specified in vivo and in vitro tests annually, with the preponderance of work required to be performed by the prime contractor. The anticipated period of performance includes a base period from 1/01/2027 to 12/31/2027, with the possibility of multiple 12-month option periods. The contractor must possess an AAALAC International accredited animal facility and meet specific animal welfare assurance requirements. This notice is for market research only to determine capability and availability of qualified sources, not a solicitation for proposals.